/Berkshire%20Hathaway%20Inc_%20%20logo%20and%20money%20background-%20by%20photo_gonzo%20via%20Shutterstock.jpg)
Davita hit its 23rd new 52-week low on Tuesday. Its stock is now within a few dollars of trading in double digits. That’s not a good thing, given that its share price was nearly $180 a year ago.
/DaVita%20Inc%20sign%20on%20building-by%20photo-denver%20via%20Shutterstock.jpg)
As DaVita has underperformed relative to the Dow over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Appointments of Chief People Officer and Chief Strategy Officer underscore commitment to innovation and people-first approach
2 Small-Cap Stocks to Keep an Eye On and 1 That Underwhelm
If you want accessible, useful, and downright cheap funds to anchor your portfolio, these three index funds can do it better than most.
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know
Berkshire Hathaway has just released its 13F filing for the third quarter of 2025.